XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
http://www.ipfcommunity.it/area-medici/aggiornamenti-area-medici/news-aggiornamenti-area-medici/trattamento-nintedanib-nella-pratica-clinica-lesperienza-tre-centri-riferimento-inglesi/60%Daily2017-07-13 15:12
http://www.ipfcommunity.it/area-medici/aggiornamenti-area-medici/news-aggiornamenti-area-medici/fattori-predittivi-risposta-pirfenidone-pazienti-ipf/60%Daily2017-07-13 15:33
http://www.ipfcommunity.it/aggiornamenti/news/la-settimana-mondiale-dellipf/60%Daily2017-10-06 08:12
http://www.ipfcommunity.it/area-medici/aggiornamenti-area-medici/news-aggiornamenti-area-medici/trattamento-lungo-termine-dellipf-nintedanib-un-update-dei-dati-dello-studio-inpulsis/60%Daily2017-07-13 15:42
http://www.ipfcommunity.it/area-medici/congressi/highlights-dai-congressi/ers-congress-2016/news-ers-congress-2016/trattamento-nintedanib-nella-pratica-clinica-lesperienza-tre-centri-riferimento-inglesi-2/60%Daily2017-07-18 13:29
http://www.ipfcommunity.it/area-medici/congressi/highlights-dai-congressi/ers-congress-2016/news-ers-congress-2016/fattori-predittivi-risposta-pirfenidone-pazienti-ipf-2/60%Daily2017-07-18 13:27
http://www.ipfcommunity.it/area-medici/congressi/highlights-dai-congressi/ers-congress-2016/news-ers-congress-2016/trattamento-lungo-termine-dellipf-nintedanib-un-update-dei-dati-dello-studio-inpulsis-2/60%Daily2017-07-18 13:21
http://www.ipfcommunity.it/area-medici/congressi/highlights-dai-congressi/ers-congress-2016/focus/ipf-clinical/60%Daily2017-07-26 10:04
http://www.ipfcommunity.it/area-medici/congressi/highlights-dai-congressi/ers-congress-2016/news-ers-congress-2016/limpatto-dellipf-sullo-status-salute-sulla-qualita-vita-dati-pratica-clinica/60%Daily2017-07-18 13:18
http://www.ipfcommunity.it/area-medici/congressi/highlights-dai-congressi/ers-congress-2016/news-ers-congress-2016/esposizione-ambientale-nei-pazienti-ipf-nella-pratica-clinica-lanalisi-ad-interim-del-registro-proof/60%Daily2017-07-16 12:11
http://www.ipfcommunity.it/area-medici/congressi/highlights-dai-congressi/ers-congress-2016/news-ers-congress-2016/correlazione-variazione-fvc-estensione-della-fibrosi-gravita-dellenfisema-nella-ipf/60%Daily2017-07-16 12:07
http://www.ipfcommunity.it/area-medici/congressi/highlights-dai-congressi/ers-congress-2016/focus/where-do-we-go-from-here-personalised-medicine-and-patient-focused-care-ipf/60%Daily2017-07-26 10:06
http://www.ipfcommunity.it/area-medici/congressi/highlights-dai-congressi/ers-congress-2016/news-ers-congress-2016/sicurezza-lungo-termine-della-combinazione-nintedanibpirfenidone-pazienti-giapponesi-affetti-ipf/60%Daily2017-07-16 11:55
http://www.ipfcommunity.it/area-medici/congressi/highlights-dai-congressi/ers-congress-2016/news-ers-congress-2016/nintedanib-nella-pratica-clinica-dati-del-compassionate-use-program-tedesco/60%Daily2017-07-16 11:38
http://www.ipfcommunity.it/area-medici/congressi/highlights-dai-congressi/ers-congress-2016/news-ers-congress-2016/modifiche-posologiche-intensita-dosaggio-trattamento-pirfenidone/60%Daily2017-07-16 11:33
http://www.ipfcommunity.it/area-medici/congressi/highlights-dai-congressi/ers-congress-2016/focus/early-diagnosis-of-ipf-patient-journey/60%Daily2017-07-14 12:04
http://www.ipfcommunity.it/area-medici/congressi/highlights-dai-congressi/ers-congress-2016/news-ers-congress-2016/lesperienza-dei-pazienti-ipf-terapia-nintedanib-pirfenidone/60%Daily2017-07-16 11:34
http://www.ipfcommunity.it/area-medici/congressi/highlights-dai-congressi/ers-congress-2016/news-ers-congress-2016/effetto-nintedanib-sulla-health-related-quality-of-life-pazienti-affetti-ipf/60%Daily2017-07-16 10:29
http://www.ipfcommunity.it/area-medici/congressi/highlights-dai-congressi/ers-congress-2016/news-ers-congress-2016/effetto-anti-fibrotico-nintedanib-pirfenidone-colture-cellulari-tridimensionali-bidimensionali/60%Daily2017-07-16 10:22